THC Therapeutics (THCT) 10-Q2023 Q2 Quarterly report

Filed: 8 Jan 24, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Cox, dispute, judge, Moxley, Paul, pending, pursuing, reduction, remanded, renewed, scheduled, Scott, trial

Removed: account, acquisition, age, alternative, appeal, Article, assistant, bar, Beneficial, bifurcate, built, California, campaign, capitalize, carry, closing, competitor, component, convert, converted, country, customize, depending, deprivation, designated, digital, display, divided, dividend, eighteen, eighty, eligible, entitled, facility, Fixed, floatation, foot, governed, Groupon, guest, healthcare, Hedging, Holder, hundred, invite, juice, Kampuchea, launch, launching, lead, leasing, liquidation, local, locally, manager, mandatory, membership, million, national, natural, networking, obtaining, OTC, oxygen, pace, pain, personnel, planned, point, population, preceding, preference, primary, provision, Radio, redeemed, refrigeration, rehabilitation, Rest, sensory, separately, service, signage, size, sleep, social, southern, square, storage, submitted, therapy, thousand, tour, True, TV, twenty, typically, unisex, unrealized, utilized, vi, vote, voting, VWAP

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

THCT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of THC Therapeutics, Inc. (the "Company") on Form 10-Q for the fiscal period ended January 31, 2023 (the "Report"), I, Scott Cox, Interim Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	1)	The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and

	2)	The information contained in the Report fairly presents, in all material respects, the Company's financial position and results of operations.

Date: January 8, 2024	By:	/s/ Scott Cox
		Scott Cox
		Interim Chief Executive Officer (Principal Executive Officer & Principal Accounting Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.